Expert Opinion on Biological Therapy's 2026 Journal Metrics Score is 3.3, ranking Q1 in Genetics and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 4.13.
Not available — there are not enough recent PubMed records with both received and accepted dates.
No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
76 of 501 works · same type, year & subfield
4 works · same type, year & subfield
Above field-year expectation
of 1,616 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.07, so its typical recent paper runs about 7% above its field benchmark.
15.2% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
501 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Expert Opinion on Biological Therapy publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Immunology | Q2 |
| Genetics | Q1 |
| Radiology, Nuclear Medicine and Imaging | Q1 |
| Oncology | Q2 |
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
Expert Opinion on Biological Therapy's 2026 Journal Metrics Score is 3.3, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
Expert Opinion on Biological Therapy's best quartile is Q1. By OpenAlex subfield: Q2 in Immunology; Q1 in Genetics; Q1 in Radiology, Nuclear Medicine and Imaging; Q2 in Oncology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Expert Opinion on Biological Therapy will not match this score exactly. Compare journals using one source at a time.
Comparable journals include Biodrugs, Biologics-Targets & Therapy, Immunological Reviews, and Journal For Immunotherapy of Cancer. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.